CD8A and neoplasm: This synergistic enhancement of the immune function by metformin was further evidenced in human studies on tumor-infiltrating lymphocytes (TILs), where a reduction in CD8+ effector T cells and FoxP3+ T regulatory cells was observed in head and neck squamous cell carcinoma [44], mirroring our observations.